Marc Rohrschneider, PhD Novartis Pharmaceuticals AG

Marc received his Master’s Degree in English and Biology from Ruhr-University Bochum, Germany and his Ph.D. in Pharmaceutical Technology from Heinrich-Heine-University Düsseldorf, Germany. He joined the medical device industry in 2001 as a Project Manager in Regulatory Affairs for Respimat® Soft Mist Inhaler with STEAG microParts GmbH, Germany. From 2004 -2011 he held positions of increasing responsibility in the development of inhalation devices and formulations within Boehringer Ingelheim. In 2012 he joined Boehringer Ingelheim’s Biopharma Division as Senior Manager, Technology & Innovation Delivery, before being appointed Head of Device/Combination Product Development for biopharmaceuticals in 2014. In July 2017 Marc moved to Basel and joined Novartis Pharma AG as Head of New Technologies for Device Development and Commercialisation, within the Technical Research and Development division.